Tobias Peikert is a Respiratory physician affiliated with Mayo Clinic. OpenAlex indexes 201 publications with 8,886 citations (h-index 41); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 1st St SW
Rochester, MN 559050001
Telephone
507-284-2511Provider last certified this registry record 19 Aug 2020.
Clinical trials
- Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Sponsor: Wake Forest University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- INTUITIVE SURGICAL, INC.Program year20241 payment
- AstraZeneca Pharmaceuticals LPProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
56%Corticosteroid56%Prednisone100%Part D<11 patientsAnti-infectives
44%Short-acting sulfonamides44%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2012–2015 per NIH RePORTER. The latest:
- Anti-Tumor Immunity in Response to a Modified Vaccine Strain Measles Virus
Mayo Clinic Rochester
FY2015$164,160K23CA159391 - Anti-Tumor Immunity in Response to a Modified Vaccine Strain Measles Virus
Mayo Clinic Rochester
FY2014$164,160K23CA159391 - Anti-Tumor Immunity in Response to a Modified Vaccine Strain Measles Virus
Mayo Clinic Rochester
FY2013$164,160K23CA159391
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Do we need to see to believe?—radiomics for lung nodule classification and lung cancer risk stratification
Journal of Thoracic Disease
2020 - Chromosomal rearrangements and their neoantigenic potential in mesothelioma
Translational Lung Cancer Research
2020
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
Ayalew Tefferi, MD
Mayo Clinic
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”